ANNABELLE RIVERA: Open Payments
NPI 1871250191 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 32 payments from 10 companies in 2025. Trend: 2023 $1,151 · 2024 $869 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $348 |
| ABBVIE INC. | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Lilly USA, LLC | 3 | $76 |
| PFIZER INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: Ozempic, UBRELVY, NURTEC ODT, FARXIGA, MOUNJARO, ZEPBOUND, TRINTELLIX, Saxenda.
Industry payments across TX — which companies pay providers there.
